Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients
18th Dec 2005, 00:17 GMT
A new cancer treatment that combines the power of radioactive monoclonal antibodies with high-dose chemotherapy and the patient's own blood stem cells is showing encouraging results in early studies, according to researchers at City of Hope Cancer Center. Results of the clinical trial, conducted on patients with mantle cell lymphoma (MCL), a type of non-Hodgkins lymphoma, were announced today at the American Society of Hematology's 47th annual meeting... click link for more info.
Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients related news:
- Early, Deep Response With Imatinib Reduces Risk for CML Relapse — Medscape Headlines
- Research shows link between genetics and cancer drug — News & Features from Minnesota Public Radio
- Tositumomab Plus Stem Cell Transplant Induces Remission in Refractory B-Cell Lymphoma — Medscape Headlines
- Gleevec Lowers Leukemia Risks — WSJ.com: What's News Europe
- Clonotypic analysis of acute lymphoblastic leukemia with a double TEL-AML1 fusion at onset and relapse — Leukemia
- Chronic leukemia patients may benefit by green tea extracts — Health News
- SABCS: Shorter Chemotherapy Regimen Plus Taxol Reduces Breast Cancer Recurrence — MedPage Today Hematology/Oncology
- AnorMED announces 73% of cancer patients who failed prior chemotherapy mobilizations succeed in collecting enough stem cells for transplant in MOZOBIL compassionate use program — StratWire - Business of Healthcare NewsFeed
- Trial shows long term benefit of Novartis leukemia drug — Pharmaceutical Business Review Online
- Green tea extract may help some chronic leukemia patients — Science Blog -
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes